Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Botulinum neurotoxin type A, free of complexing proteins
DRUG
2 trials
Sponsors
Merz Pharmaceuticals GmbH
Conditions
Glabellar Frown Lines
Healthy
Phase 1
Evaluate the Migration Potential of Xeomin® Compared to Two Other Botulinum Toxin Type A Products
Completed
NCT00515944
Merz Pharmaceuticals GmbH
Healthy
Start: 2007-08-31
End: 2008-06-30
Target: 30
Updated: 2009-04-01
Phase 2
Finding of Optimal Dose for NT 201 in the Treatment of Glabellar Frown Lines
Completed
NCT00430586
Merz Pharmaceuticals GmbH
Glabellar Frown Lines
Start: 2006-11-30
End: 2007-08-31
Updated: 2011-08-03